Board/Management Information • Jun 20, 2011
Board/Management Information
Open in ViewerOpens in native device viewer
News Details
Corporate | 20 June 2011 16:57
Change in the Supervisory Board of MeVis Medical Solutions AG
MeVis Medical Solutions AG / Key word(s): Change of Personnel
20.06.2011 / 16:57
CORPORATE NEWS
Change in the Supervisory Board of MeVis Medical Solutions AG
Bremen, June 20, 2011 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading software company in medical imaging, today announced a change in their Supervisory Board.
Mr. Peter Kuhlmann-Lehmkuhle, Managing Partner of C. Melchers GmbH & Co. KG, was elected to the Supervisory Board in the company's Annual General Meeting on June 15, 2011. Simultaneously, the previous Supervisory Board Members Prof. Dr. Heinz-Otto Peitgen and Dr. Jens Kruse were elected to the company's control panel. Mr. Kuhlmann-Lehmkuhle is replacing the former Supervisory Board member Dr. Peter Zencke, who has not been available for a new term.
'With Peter Kuhlmann-Lehmkuhle, we have gained an experienced and successful Bremen entrepreneur for our Supervisory Board. Being a pre-IPO shareholder he certainly will shape our future business development. Therefore, we look forward to working with him', says Dr. Carl. J. G. Evertsz, chairman of the MeVis Medical Solutions AG Executive Board. Furthermore, the Executive and Supervisory Board both expressed their gratitude to Dr. Peter Zencke, who will be available to the company as an external consultant.
In the Supervisory Board Meeting held on June 15, 2011, Prof. Dr. Peitgen was elected as Chairman of the Supervisory Board and Dr. Jens Kruse as his Deputy.
For further information please visit http://www.mevis.de .
MeVis Medical Solutions AG was founded in 1997 and is one of the world's leading independent manufacturers and vendors of medical imaging software with focus on dedicated, disease-oriented clinical applications. Over the past few years, there has been an enormous increase in the complexity and volume of medical imaging data derived from digital imaging processes such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US). MeVis Group's products analyze and process this data in such a way as to provide medical professionals with crucial information for early detection, diagnosis and intervention in the areas of cancer and lung diseases as well as neurological conditions. The Group develops its software solutions in close consultation with the world's leading medical experts and original equipment makers in the medical technology sector and primarily markets this software via these partnerships.
************************************************************************
| Corporate Contact: |
| MeVis Medical Solutions AG Dr. Kai Holtmann Investor Relations Manager Tel: +49 421 22495-63 E-mail: [email protected] |
End of Corporate News
20.06.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Universitätsallee 29 | |
| 28359 Bremen | |
| Deutschland | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 11 |
| E-mail: | [email protected] |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart |
| End of News | DGAP News-Service |
| - - - |
| 129190 20.06.2011 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.